1st Quarter - Termination

CHRISTY ELLERBEE CONSULTING, LLC for INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.)

Firm
Client
Income
—
Expenses
—
Terminated
Mar 31, 2016

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821 and S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536 and S. 1455 TREAT ACT.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1455 (114th), S. 707 (114th), H.R. 1821 (114th), H.R. 2872 (114th), H.R. 2536 (114th)

Health Issues HCR

H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821 and S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536 and S. 1455 TREAT ACT.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2536 (114th), H.R. 1821 (114th), S. 707 (114th), S. 1455 (114th), H.R. 2872 (114th)

Pharmacy PHA

H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821 and S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536 and S. 1455 TREAT ACT.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2536 (114th), S. 1455 (114th), S. 707 (114th), H.R. 2872 (114th), H.R. 1821 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.